把 intravitreal bevacizumab 与 Nd 相结合: 为 valsalva 的钇铝柘榴石激光 hyaloidotomy pre 有斑点的出血并且观察内部限制膜变化: spectralis 研究

• 作者: Lei Chen Li-Min Liu Rui Hua Yue-Dong Hu Yun Zhou
• 来源期刊: 国际眼科杂志：英文版
• 学科: 医学
• 关键词: VALSALVA RETINOPATHY spectralis OCT internal LIMITING membrane BEVACIZUMAB
• 年，卷（期）: 2013,（2）
• 页码范围: 242-245
• 页数: 4页
• 分类号: R774.5

摘要

Valsalva retinopathy was described as a particular form of retinopathy, pre-retinal and subinternal limiting membrane haemorrhages in nature that rarely may break through and become subhyloid or intravitreal, secondary to a sudden increase in intrathoracic pressure. We reported a new way that Nd:YAG laser for ILM hyaloidotomy in order to drain the sub-ILM blood into vitreous cavity combined with intravitreal bevacizumab to improve the absorption of blood. Therapeutic alliance make significant outcome, protecting vision in time. We used spectralis OCT to observe sub-ILM mix cells and special ILM structure in this lesion for the first time, as the spectralis OCT can reach histology level imagination.